EMA To Consider Approvals For Eight Orphans, Including Vertex’s CF Drug Alyftrek

 
• By Francesca Bruce
  
The EMA's human medicines committee will this week issue opinions on whether 19 medicines should be approved in the EU. (Shutterstock)

More from Europe

More from Rare Diseases